Ameriprise’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $73.6M | Sell |
|
|||||
|
2021
Q1 | $63.6M | Sell |
|
|||||
|
2020
Q4 | $367M | Sell |
|
|||||
|
2020
Q3 | $584M | Sell |
|
|||||
|
2020
Q2 | $677M | Sell |
|
|||||
|
2020
Q1 | $564M | Buy |
|
|||||
|
2019
Q4 | $673M | Buy |
|
|||||
|
2019
Q3 | $571M | Sell |
|
|||||
|
2019
Q2 | $829M | Sell |
|
|||||
|
2019
Q1 | $933M | Sell |
|
|||||
|
2018
Q4 | $681M | Sell |
|
|||||
|
2018
Q3 | $986M | Sell |
|
|||||
|
2018
Q2 | $925M | Sell |
|
|||||
|
2018
Q1 | $833M | Buy |
|
|||||
|
2017
Q4 | $850M | Buy |
|
|||||
|
2017
Q3 | $896M | Buy |
|
|||||
|
2017
Q2 | $751M | Buy |
|
|||||
|
2017
Q1 | $746M | Buy |
|
|||||
|
2016
Q4 | $697M | Buy |
|
|||||
|
2016
Q3 | $577M | Sell |
|
|||||
|
2016
Q2 | $704M | Buy |
|
|||||
|
2016
Q1 | $738M | Buy |
|
|||||
|
2015
Q4 | $993M | Sell |
|
|||||
|
2015
Q3 | $858M | Buy |
|
|||||
|
2015
Q2 | $896M | Buy |
|
|||||
|
2015
Q1 | $549M | Buy |
|
|||||
|
2014
Q4 | $461M | Sell |
|
|||||
|
2014
Q3 | $492M | Buy |
|
|||||
|
2014
Q2 | $435M | Buy |
|
|||||
|
2014
Q1 | $373M | Sell |
|
|||||
|
2013
Q4 | $352M | Buy |
|
|||||
|
2013
Q3 | $257M | Sell |
|
|||||
|
2013
Q2 | $223M | Buy |
|